Emvision Medical Devices Ltd
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospita… Read more
Market Cap & Net Worth: Emvision Medical Devices Ltd (EMV)
Emvision Medical Devices Ltd (AU:EMV) has a market capitalization of $92.65 Million (AU$149.63 Million) as of March 18, 2026. Listed on the AU stock exchange, this Australia-based company holds position #20565 globally and #353 in its home market, demonstrating a 1.90% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Emvision Medical Devices Ltd's stock price AU$1.61 by its total outstanding shares 92938604 (92.94 Million).
Emvision Medical Devices Ltd Market Cap History: 2018 to 2026
Emvision Medical Devices Ltd's market capitalization history from 2018 to 2026. Data shows growth from $20.14 Million to $92.65 Million (25.74% CAGR).
Emvision Medical Devices Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Emvision Medical Devices Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
20.28x
Emvision Medical Devices Ltd's market cap is 20.28 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $20.14 Million | $492.67K | -$845.04K | 40.88x | N/A |
| 2019 | $42.30 Million | $1.14 Million | -$2.96 Million | 37.26x | N/A |
| 2020 | $179.54 Million | $980.72K | -$5.08 Million | 183.07x | N/A |
| 2021 | $154.22 Million | $1.70 Million | -$8.40 Million | 90.78x | N/A |
| 2022 | $106.46 Million | $4.36 Million | -$6.11 Million | 24.42x | N/A |
| 2023 | $97.54 Million | $6.97 Million | -$3.87 Million | 13.99x | N/A |
| 2024 | $109.05 Million | $11.22 Million | -$2.73 Million | 9.72x | N/A |
| 2025 | $102.43 Million | $5.05 Million | -$9.81 Million | 20.28x | N/A |
Competitor Companies of EMV by Market Capitalization
Companies near Emvision Medical Devices Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Emvision Medical Devices Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Emvision Medical Devices Ltd Historical Marketcap From 2018 to 2026
Between 2018 and today, Emvision Medical Devices Ltd's market cap moved from $20.14 Million to $ 92.65 Million, with a yearly change of 25.74%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$92.65 Million | -9.55% |
| 2025 | AU$102.43 Million | -6.07% |
| 2024 | AU$109.05 Million | +11.80% |
| 2023 | AU$97.54 Million | -8.38% |
| 2022 | AU$106.46 Million | -30.97% |
| 2021 | AU$154.22 Million | -14.10% |
| 2020 | AU$179.54 Million | +324.49% |
| 2019 | AU$42.30 Million | +110.00% |
| 2018 | AU$20.14 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Emvision Medical Devices Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $92.65 Million USD |
| MoneyControl | $92.65 Million USD |
| MarketWatch | $92.65 Million USD |
| marketcap.company | $92.65 Million USD |
| Reuters | $92.65 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.